With coronavirus affecting the senior population particularly hard, the pharmaceutical company Eli Lilly is launching a COVID-19 antibody treatment study focused on those in assisted living facilities.
With coronavirus affecting the senior population particularly hard, the pharmaceutical company Eli Lilly is launching a COVID-19 antibody treatment study focused on those in assisted living facilities.
(Part 1 of 2) The pandemic is not just costing jobs, but also leaving millions of people without health coverage. And author BJ..